Astellas Pharma Inc.

ALPMF | OTC

Price Alert Chart Builder DCF Calculator

$15.25

+$1.40 (+10.11%)

Sep 21, 2026, 4:00 PM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021	FY 2020 Mar 30, 2020
Revenue	1.91T	1.6T	1.52T	1.3T	1.25T	1.3T
Cost of Revenue	349.21B	292.49B	288.35B	253.01B	246.06B	276.74B
Gross Profit	1.56T	1.31T	1.23T	1.04T	1T	1.02T
Operating Income	41.04B	25.52B	133.03B	220.02B	136.05B	243.99B
Interest Income	7.87B	11.46B	8.11B	6.15B	11.61B	4.36B
Pretax Income	31.24B	24.97B	132.36B	156.89B	145.32B	245.35B
Net Income	50.75B	17.05B	98.71B	124.09B	120.59B	195.41B
Selling & General & Admin	843.03B	740.11B	630.27B	548.84B	504.32B	499.3B
Research & Development	327.65B	294.2B	276.13B	246.01B	224.49B	224.23B
Other Expenses	351.4B	251.36B	38.44B	28.28B	139.09B	54.93B
Operating Expenses	1.52T	1.29T	944.84B	823.13B	867.89B	778.45B
Interest Expense	17.68B	12.01B	8.78B	4.95B	2.34B	3B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.87T	1.58T	1.23T	1.08T	1.11T	1.06T
Income Tax Expense	-19.51B	7.92B	33.65B	32.8B	24.73B	49.94B
Shares Outstanding (Basic)	1.8B	1.79B	1.82B	1.85B	1.86B	1.88B
Shares Outstanding (Diluted)	1.8B	1.8B	1.83B	1.85B	1.86B	1.88B
EPS (Basic)	28.35	9.50	54.24	67.08	64.93	104.15
EPS (Diluted)	28.24	9.47	54.09	67.05	64.90	104.08
EBITDA	248.05B	194.81B	337.39B	297.83B	323.58B	333.88B
EBIT	48.91B	36.97B	231.65B	218.15B	250.93B	248.35B
Depreciation & Amortization	199.13B	157.84B	105.74B	79.68B	72.65B	66.4B